Northwest Biotherapeutics, Inc. (BST:NBYB)
0.2360
+0.0080 (3.51%)
At close: Sep 26, 2025
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of €329.98 million as of September 26, 2025. Its market cap has decreased by -6.93% in one year.
Market Cap
329.98M
Enterprise Value
397.75M
Revenue
931.54K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.24
Market Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 11.37M to 329.98M, an increase of 2,801.00%. That is a compound annual growth rate of 15.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 331.10M | -5.81% |
Dec 31, 2024 | 351.54M | -52.72% |
Dec 29, 2023 | 743.52M | -4.28% |
Dec 30, 2022 | 776.73M | 33.17% |
Dec 31, 2021 | 583.27M | -43.13% |
Dec 31, 2020 | 1.03B | 790.70% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 262.27B |
Siemens Aktiengesellschaft | 173.58B |
Deutsche Telekom AG | 136.67B |
Allianz SE | 132.93B |
Rheinmetall AG | 90.78B |
Siemens Energy AG | 82.78B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.13B |
Deutsche Bank Aktiengesellschaft | 57.72B |